https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/dr-wendy-heywood-awarded-investigator-initiated-research-proposal-shire-pharmaceuticals/
Dr Wendy Heywood awarded investigator initiated research proposal from Shire Pharmaceuticals
28 Jun 2016, 2:01 p.m.
Following NIHR Great Ormond Street BRC support, which led to the creation of a high-throughput targeted proteomic urine test, Dr Wendy Heywood has been awarded an industry investigator initiated award from Shire Pharmaceuticals.
This award is for a Great Ormond Street Hospital (GOSH) research nurse to facilitate the clinical sample collection pipeline and manage a database of patient samples and clinical information. This Rare Disease Sample Collection will allow researchers at the UCL Institute of Child Health (ICH) and clinicians from the GOSH Metabolic disease clinic, to find new biomarkers, new disease mechanisms, design new treatments and test patients.
This streamlined ICH-GOSH collaboration will enable translation of current and future new metabolic disease biomarkers to clinical laboratories for use in future clinical trials of existing and novel therapies.
Professor Waseem Qasim named in list of leading global health leaders
Professor Waseem Qasim, Consultant at GOSH and Professor of Cell and Gene Therapy at University College London has been named in TIME magazine’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.
Alyssa Tapley named in list of leading global health leaders
GOSH patient, Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.
GOSH joins partnership to boost early diagnosis and deliver better treatments
GOSH is partnering with LifeArc to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.
How linked health and education data is changing what we know about children with neurodisability
Children with neurodisability often have complex health and educational needs, but population level data on long term outcomes remains limited. New research from GOS-ICH addresses this gap using one of the largest national birth cohorts to date.